首頁 > 市場調查報告書 > 食物/飲料

機能性食品

市場調查報告書

商品編碼

1455746

全球減肥藥市場 - 2023-2030

Global Diet Pills Market - 2023-2030

出版日期: 2024年03月26日 | 出版商:

DataM Intelligence | 英文 240 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年，全球減肥藥市場規模達33.4億美元，預計2030年將達到56.5億美元，2023-2030年預測期間CAGR為6.8%。

由於肥胖病例的增加，減肥藥在市場上越來越受歡迎。超重和肥胖已成為成人和兒童的主要問題。根據《2023 年世界衛生統計》，預計到 2022 年，約有 3,700 萬名五歲以下兒童患有肥胖症。隨著兒童長大成人，兒童肥胖可能導致過早死亡和殘疾。

人們健康意識的提高正在增加減肥的方法。根據《2023 年減肥統計》，約 40% 的人透過避免節食來減肥，近 30% 的人願意阻止體重增加。減肥藥在體重管理方面的便利性和有效性正在推動其在全球範圍內的流行。

FDA 和其他組織對減肥藥物的批准增加，積極推動了市場成長。例如，2021年，Weglovy品牌的索馬魯肽被FDA批准用於治療成人超重和肥胖。北美地區的大力促銷活動和新產品開發使其在全球市場的佔有率增加至1/3。

動力學

肥胖症盛行率不斷上升

久坐生活方式的人被迫食用高糖和高脂肪的加工產品。由於日程繁忙，人們開始選擇即食食品。高熱量食物的消費增加和體力活動的減少導致肥胖等生活方式疾病的高發生率。此外，工作人群面臨的各種狀況，如壓力和睡眠不足，也是導致肥胖的一些原因。

世界肥胖聯合會2023預測，肥胖病例正在迅速增加，未來12年內全球一半以上的人口可能面臨肥胖和超重問題。人們日益增強的健康意識正在推動可減輕體重和提供健康身體的產品市場的發展。減肥藥對減肥的幫助可以成為市場更大的動力。

增加使用膳食補充劑來減肥

據 NIH 稱，大約 15% 的美國成年人登記使用減肥膳食補充劑。據報道，其中女性使用藥物的比例為 21%，而男性使用比例為 10%。各種形式的膳食補充劑（例如片劑、膠囊和粉末形式）的出現推動了其擴張機會。

膳食補充劑具有抑制食慾和增加新陳代謝的功能，透過燃燒脂肪對體重管理產生正面影響。越來越多的新產品推出市場，越來越受到消費者的關注。例如，2023年7月，減肥補充劑品牌Hydroxycut推出了新產品線Hardcore。此系列產品包括膠囊、軟糖和飲料棒。

對副作用的擔憂

減肥藥可能有助於減肥，但可能會引起一些副作用。胃腸道問題是減肥藥最常見的副作用，包括腹瀉、脹氣和胃痛。研究也發現，減肥藥會導致肝臟和腎臟出現嚴重的健康問題。此類藥物可能會增加甲狀腺癌的風險，並可能降低血糖水平。此類減肥藥危及生命的副作用使人們擔心使用它們，阻礙了市場規模的擴大。

減肥藥在最終產品之前需要經過多次試驗，這可能需要更多的投資。此外，組織和政府對減肥藥核准的嚴格規定也會阻礙市場業務。出於安全考慮，美國FDA限制或禁止了多種減肥藥。例如，2023年8月，FDA發佈公告，聲稱不要購買Alfia減肥藥，因為其含有西布曲明物質，該物質已於2010年從市場下架。

Diet pills are gaining immense popularity in the market due to increasing obesity cases. Overweight and obesity have become a major problem in adults and children. According to World Health Statistics 2023, it is identified that there were around 37.0 million children under five years of age suffering from obesity in 2022. Childhood obesity can lead to premature death and disability as children grow into adults.

Increased health consciousness among people is increasing the approaches for weight loss. According to Weight-Loss Statistics 2023, about 40% of people are avoiding diet to lose weight, and nearly 30% of people are willing to prevent their weight gain. The convenience and effectiveness of diet pills in weight management are driving thier popularity globally.

Increased approvals of weight loss drugs by the FDA and other organizations positively drive market growth. For instance, in 2021, Semaglutide, from the Weglovy brand, was approved by the FDA to treat overweight and obesity in adults. The high promotional activities and new product developments in North America increase its share to 1/3rd of global market.

Dynamics

Growing Prevalence of Obesity

People with sedentary lifestyles are forced to eat processed products high in sugars and fats. With hectic schedules, people are choosing ready-to-eat food products. The increased consumption of food with higher calories and reduced physical activity leads to a high prevalence of lifestyle diseases such as obesity. In addition, the working population are experiencing various condition, such as stress and poor sleep, which are some of the causes of obesity.

The World Obesity Federation 2023 predicts that obesity cases are rapidly increasing, and more than half of the worldwide population might deal with obesity and overweight in the coming 12 years. The rising health consciousness among people is driving the market for products that can reduce their weight and provide a healthy body. The help of diet pills in reducing weight can be a greater driving force for the market.

Increased Use of Dietary Supplements for Weight Loss

According to NIH, approximately 15% of U.S. adults are registered to use weight-loss dietary supplements. Among these, women are reported to use 21 % of pills, while men are subjected to the 10% use. The availability of dietary supplements in various forms, such as tablets, capsules, and powder forms, drives its expansion opportunities.

The functionality of dietary supplements in suppressing the appetite and increasing metabolism positively affects weight management by burning fat. The increased number of new products launched into the market is gaining consumer's attention. For instance, in July 2023, Hydroxycut, a weight-loss supplements brand, introduced its new product line, Hardcore. This line range products comprises capsules, gummies and drink sticks.

Concerns About Side Effects

The diet pills may help weight loss but can cause several side effects. Gastrointestinal problems are diet pills' most common side effects, including diarrhoea, gas and stomach ache. It is also observed that weight loss pills can lead to severe health issues in the liver and kidneys. Such pills may increase thyroidal cancer risk and may lower blood sugar levels. Life-threatening side effects of such diet pills are making people worried about using them, hindering the market size expansion.

The diet pills need to go through several trials before finalizing the product, which may need more investments in them. In addition, the strict regulations about diet pill approvals from organizations and governments can hamper the market business. Considering the safety concerns, U.S. FDA restricted or banned several weight loss pills. For instance, in August 2023, the FDA released a public notification claiming not to purchase Alfia weight loss pills due to its sibutramine substance, that is removed from the market in 2010.

Segment Analysis

The global diet pills market is segmented based on source, type, form, age group, function, usage, distribution channel, application, end-user and region.

Increased Health Awareness

The global diet pills market is segmented based on weight loss and body-shaping usage. This market's weight loss pills segment is gaining immense popularity among teenagers and adults, leading to a larger share of this segment. The rising health concerns of being overweight such as high blood pressure, type 2 diabetes and heart problems, encourage people to take action to lose weight, driving the segment growth.

According to Weight-Loss Statistics 2023, about 40% of people are avoiding diet to lose weight, and just under 30% of people are willing to prevent their weight gain. The rising number of people willing to lose weight and use diet pills to reduce their weight positively impacts the segment's growth. In addition, the new product launches from the key market players in the weight loss category increase the segment demand.

Geographical Penetration

Increased Obesity Cases

North America held the largest share of the global diet pills market. The increased self-awareness about weight management is the key factor driving the market in this region. The increased employment-population ratio of this region has a greater influence on their food patterns. The hectic lifestyles of people increased their consumption of processed food products.

The unhealthy lifestyle of people of this region has led to increased obesity. According to the Centers for Disease Control and Prevention 2023, United States has around 41.9% of adults and 19.7 % of children suffering from obesity. The increased prevalence of obesity and the increase in people's awareness about weight loss drive this region's diet pills market growth.

According to UNC Gillings School of Global Public Health 2021, about 34% of Americans willing to lose weight have used weight loss supplements. The stronger influence of social media on people's lifestyles and more importance for body shape maintenance may positively affect the diet pills market as people are willing to adopt diet pills to lose weight.

Competitive Landscape

The major global players in the market include Nirvasa, Applied Nutrition, Lovate Health Sciences Inc, Chong's Health Care, Healthviv, MuscleTech, Nov- Nordisk A/S, Vivus LLC, Now Foods and Herbalife.

COVID-19 Impact Analysis

The outbreak of COVID-19 had a mixed impact on the global diet pills market. The strict government regulations restricted people to their houses. The increased time for cooking in the pandemic period increased people's food intake. There is increased consumption of processed food products due to their convenience. The high calories and fats of such food products increase the prevalence of obesity.

According to NIH, there is an increased prevalence of obesity among 2 to 20-year age groups during lockdowns. People were not allowed outside their houses, decreasing their physical activity. The shutdown of gyms and exercise centers made it difficult for people to lose weight, giving rise to diet pills. The high food consumption and decreased physical activity, increased the demand for diet pills as people started their weight management.

Further, the pandemic gave rise to e-commerce sector activities. Most people started using online platforms for their necessary purchases. The accessibility and popularity of the e-commerce sector and the wide availability of diet pill products in online platforms increased the market demand. The halted supply chain activities and distribution channel processes created a little disturbance in the diet pills market.

Russia- Ukraine War Impact

The Russia-Ukraine war had a negative impact on many industrial sectors, including food support and services sector. The labor shortage and a lack of resources for the production and distribution of diet pills badly impacted the market. The supply chain and distribution channels were negatively affected, decreasing market growth.

War decreased people's affordability to high-priced products like diet pills. The war created import and export trade disruptions, resulting in product haltation in reach to target customers. The high taxes and increased prices of commodities created economic disturbances. The trade The political and economic uncertainty created due to the war had a negative impact on the diet pills market.

By Source

Leaves
Barks
Fruits and Vegetables
Roots

By Type

Prescription
Over the Counter Drugs
Herbal Supplements
Others

By Form

Tablets
Capsules
Powder
Liquid
Softgels

By Age Group

Children
Adolescents
Adults
Over Adults

By Function

Medicinal
Aroma
Others

By Usage

Weight Loss
Body Shaping

By Distribution Channels

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies

By Application

Appetite Suppression
Metabolism Raising Pills
Fat Blocking
Others

By End-User

Hospitals
Weight Loss Centers
Home Use

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In July 2023, a Denmark-based global healthcare company, Novo Nordisk, introduced its weight loss drug Wegovy in Germany.
In May 2023, Noom, a U.S.-based weight loss startup, unveiled a program prescribing new weight-reducing drugs like Wegovy.
In November 2022, a U.S.-based Audax Private Equity, announced the acquisition, of Medi-Weightloss, Inc., a weight-loss and diet pills offering company. This acquisition helps the Medi-Weightloss company to expand its business range.

Why Purchase the Report?

To visualize the global diet pills market segmentation based on source, type, form, age group, function, usage, distribution channel, application, end-user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of diet pills market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global diet pills market report would provide approximately 109 tables, 121 figures and 240 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet by Source
3.2.Snippet by Type
3.3.Snippet by Form
3.4.Snippet by Age Group
3.5.Snippet by Function
3.6.Snippet by Usage
3.7.Snippet by Distribution Channels
3.8.Snippet by Application
3.9.Snippet by End-User
3.10.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Growing Prevalence of Obesity
  - 4.1.1.2.Increased Use of Dietary Supplements for Weight Loss
- 4.1.2.Restraints
  - 4.1.2.1.Concerns About Side Effects
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID
- 6.1.2.Scenario During COVID
- 6.1.3.Scenario Post COVID
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Source

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 7.1.2.Market Attractiveness Index, By Source
7.2.Leaves
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Barks
7.4.Fruits and Vegetables
7.5.Roots

8.By Type

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.1.2.Market Attractiveness Index, By Type
8.2.Prescription
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Over the Counter Drugs
8.4.Herbal Supplements

9.By Form

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.1.2.Market Attractiveness Index, By Form
9.2.Tablets
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Capsules
9.4.Powder
9.5.Liquid
9.6.Softgels

10.By Age Group

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.1.2.Market Attractiveness Index, By Age Group
10.2.Children
- 10.2.1.Introduction
- 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3.Adolescents
10.4.Adults
10.5.Over Adults

11.By Function

11.1.Introduction
- 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 11.1.2.Market Attractiveness Index, By Function
11.2.Medicinal
- 11.2.1.Introduction
- 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3.Aroma
11.4.Others

12.By Usage

12.1.Introduction
- 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 12.1.2.Market Attractiveness Index, By Usage
12.2.Weight Loss
- 12.2.1.Introduction
- 12.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3.Body Shaping

13.By Distribution Channels

13.1.Introduction
- 13.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channels
- 13.1.2.Market Attractiveness Index, By Distribution Channels
13.2.Hospital Pharmacies
- 13.2.1.Introduction
- 13.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
13.3.Drug Stores & Retail Pharmacies
13.4.Online Pharmacies

14.By Application

14.1.1.Introduction
14.1.2.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
14.1.3.Market Attractiveness Index, By Application

14.2.Appetite Suppression
- 14.2.1.Introduction
- 14.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
14.3.Metabolism Raising Pills
14.4.Fat Blocking
14.5.Others

15.By End-User

15.1.Introduction
- 15.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 15.1.2.Market Attractiveness Index, By End-User
15.2.Hospitals
- 15.2.1.Introduction
- 15.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
15.3.Weight Loss Centers
15.4.Home Use

16.By Region

16.1.Introduction
- 16.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 16.1.2.Market Attractiveness Index, By Region
16.2.North America
- 16.2.1.Introduction
- 16.2.2.Key Region-Specific Dynamics
- 16.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 16.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 16.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 16.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 16.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 16.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 16.2.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 16.2.10.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 16.2.11.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 16.2.12.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 16.2.12.1.U.S.
  - 16.2.12.2.Canada
  - 16.2.12.3.Mexico
16.3.Europe
- 16.3.1.Introduction
- 16.3.2.Key Region-Specific Dynamics
- 16.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 16.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 16.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 16.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 16.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 16.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 16.3.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 16.3.10.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 16.3.11.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 16.3.12.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 16.3.12.1.Germany
  - 16.3.12.2.U.K.
  - 16.3.12.3.France
  - 16.3.12.4.Italy
  - 16.3.12.5.Spain
  - 16.3.12.6.Rest of Europe
16.4.South America
- 16.4.1.Introduction
- 16.4.2.Key Region-Specific Dynamics
- 16.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 16.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 16.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 16.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 16.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 16.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 16.4.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 16.4.10.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 16.4.11.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 16.4.12.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 16.4.12.1.Brazil
  - 16.4.12.2.Argentina
  - 16.4.12.3.Rest of South America
16.5.Asia-Pacific
- 16.5.1.Introduction
- 16.5.2.Key Region-Specific Dynamics
- 16.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 16.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 16.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 16.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 16.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 16.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 16.5.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 16.5.10.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 16.5.11.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 16.5.12.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 16.5.12.1.China
  - 16.5.12.2.India
  - 16.5.12.3.Japan
  - 16.5.12.4.Australia
  - 16.5.12.5.Rest of Asia-Pacific
16.6.Middle East and Africa
- 16.6.1.Introduction
- 16.6.2.Key Region-Specific Dynamics
- 16.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 16.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 16.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 16.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 16.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 16.6.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 16.6.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 16.6.10.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 16.6.11.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

17.Competitive Landscape

17.1.Competitive Scenario
17.2.Market Positioning/Share Analysis
17.3.Mergers and Acquisitions Analysis

18.Competitive Landscape

18.1.Competitive Scenario
18.2.Market Positioning/Share Analysis
18.3.Mergers and Acquisitions Analysis

19.Company Profiles

19.1.Nirvasa
- 19.1.1.Company Overview
- 19.1.2.Product Portfolio and Description
- 19.1.3.Financial Overview
- 19.1.4.Key Developments
19.2.Applied Nutrition
19.3.Lovate Health Sciences Inc
19.4.Chong's Health Care
19.5.Healthviv
19.6.MuscleTech
19.7.Nov- Nordisk A/S
19.8.Vivus LLC
19.9.Now Foods
19.10.Herbal

LIST NOT EXHAUSTIVE